Welcome to this week's edition of The HCPFive! We're your essential source for the hottest healthcare news and breakthroughs, specially tailored for busy professionals. Let’s dive into the top five developments reshaping the landscape of medicine.

1. AI Revolutionizes Virtual Care at Cedars-Sinai

A groundbreaking study from Cedars-Sinai reveals that artificial intelligence can dramatically enhance care quality in virtual urgent care settings. AI recommendations were often rated higher in quality, especially when they differed from physicians’ views. However, doctors excelled at adjusting these recommendations based on real-time dialogue.

2. FDA Takes Action on AMD Treatment with ONS-5010

In exciting regulatory news, the FDA has accepted Outlook Therapeutics’ resubmission of the Biologics License Application for ONS-5010, aimed at treating wet age-related macular degeneration. With a Class 2 review designation, stakeholders eagerly await the Prescription Drug User Fee Act (PDUFA) target date of August 27, 2025.

3. Disparities in Pediatric Kidney Transplants Exposed

A recent study highlights alarming disparities in pediatric preemptive kidney transplant rates linked to socioeconomic status. Despite guidelines advocating for earlier interventions, only 25% of children with end-stage kidney disease in the U.S. received preemptive transplants in 2021, with significant gaps for those in lower socioeconomic quartiles.

4. Game-Changer: FDA Approves Dexcom G7 CGM System

Huge news for diabetes management! The FDA has cleared the Dexcom G7 continuous glucose monitoring system, designed for adults. This next-gen technology boasts an impressive wear time of 15.5 days and unmatched accuracy, making it a game-changer for glucose monitoring.

5. Promising Psoriasis Treatment: Icotrokinra Outshines Placebo

A Phase 3 trial has revealed that icotrokinra (JNJ-2113) successfully cleared skin in 75% of adolescents with moderate-to-severe plaque psoriasis after just 16 weeks. Not only did it outperform the placebo group, but it also demonstrated a better safety profile, shedding light on a potentially transformative treatment for this challenging condition.

Stay ahead in the fast-paced world of healthcare with The HCPFive, your go-to guide for essential updates and breakthroughs that matter!